The widely available diabetes drug metformin may reduce the risk of emergency room visits, hospitalisation, and death from COVID-19 by more than half if taken within four days of the start of the symptoms, according to a study.
The researchers from the University of Minnesota in the US noted that metformin, also known as Glucophage, has been used in the 1950s as an anti-viral called “Fluamine.” In more recent research, the drug has been…
in Lifestyle
Early metformin use may cut COVID-19 hospitalisation, death risk by half: Study
